User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results

  • Open access
  • PDF
  • 73.23 K
Bibliographic reference Chiritescu, G ; Dumon, K ; Mercadé, T Macarulla ; Lang, I ; Vivas, C Santos ; et. al. A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results.ESMO 20th World Congress on Gastrointestinal Cancer ((Spain) Barcelona, du 20/06/2018 au 23/06/2018). In: Annals of Oncology, Vol. 29, no.Suppl 5, p. v105 (2018)
Permanent URL http://hdl.handle.net/2078.1/213117